Mylan Board Adopts Severance Plan
- Share via
From Bloomberg News
Mylan Laboratories Inc. said its board adopted a severance plan covering about 2,200 employees to provide “enhanced severance benefits” in the event of involuntary terminations within two years of a change in control.
Billionaire financier Carl Icahn, who holds 9.7% of Mylan’s shares, offered Nov. 19 to buy the largest U.S. maker of generic drugs for about $5.38 billion to block Mylan’s proposed purchase of King Pharmaceuticals Inc. Mylan disclosed the severance plan in a government filing.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
